Recently, Zhejiang University Affiliated Obstetrics and Gynecology Hospital ushered in a major medical technology breakthrough, successfully introduced the world's first focused ultrasound non-invasive treatment robot equipment independently developed and produced by Shenzhen PRO HIFU Medical Co., LTD. The introduction of this device has brought new hope for the treatment of gynecological diseases.

Under the guidance of gynecological experts Huang Xiufeng and Li Juanqing, the medical team mastered a new skill - HIFU, namely high intensity focused ultrasound ablation (HIFUA).

HIFU is a non-invasive local treatment for uterine fibroids, and its principle is similar to that of a convex mirror focusing sunlight in a junior high school physics experiment. The low-dose ultrasound in vitro accurately "focuses" on the uterine fibroids under the real-time monitoring of ultrasound, and the focal point instantly produces high temperature, resulting in the solidification, atrophy and necrosis of the fibroids, and then gradually absorbed and discharged by the human tissues, thus achieving the effect of shrinking the fibroids. This treatment method truly realizes no operation, no bleeding, no anesthesia, no radiation, no trauma, can effectively alleviate the symptoms of patients, and minimize the harm to the female body, but also to meet the needs of women's beauty, is a safer and humane treatment choice.

It is worth mentioning that the therapeutic effect of HIFU is remarkable. For uterine fibroids, most necrotic fibroids can shrink 20%-45% of their volume 3 months after treatment. 6 months after treatment, about 60% can be absorbed; One year after the operation, 70%-80% can be absorbed. Of course, the specific data varies from person to person and is closely related to the location, type, size and individual differences of the fibroids. For women with recurrent fibroids, HIFU treatment can also be repeated or even repeated several times. Moreover, HIFU is widely used, and in addition to patients with uterine fibroids, patients with adenomyosis, abdominal endometriosis, uterine scar diverticulum pregnancy, and placenta residue can also benefit from this innovative treatment.

The introduction of this advanced equipment marks an important step in the treatment of gynecological diseases in the Affiliated Hospital of Obstetrics and Gynecology of Zhejiang University, bringing better and more cutting-edge medical services to female patients.